| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +2,777,777 | 42% | $9.00 | +$24,999,993 |
| Sells | 5 | -3,814,642 | 58% | $36.59 | -$139,578,705 |
| Net | -4 | -1,036,865 | -16% | -$114,578,712 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC | Director | $798,960,735 | -$102,400,007 | -11% | 22 Jan 2026 |
| Andrew R. Robbins | President and CEO, Director | $32,513,134 | 17 Dec 2025 | ||
| Cole Pinnow | Chief Commercial Officer | $10,271,338 | 17 Dec 2025 | ||
| John Edward Robinson | Chief Scientific Officer | $7,363,735 | -$3,486,600 | -32% | 26 Dec 2025 |
| Jessica Sachs | Chief Medical Officer | $7,123,458 | -$3,198,245 | -31% | 26 Dec 2025 |
| John L. Green | Chief Financial Officer | $7,039,397 | -$2,978,360 | -30% | 26 Dec 2025 |
| Evan D. Kearns | Chief Legal Officer | $5,886,344 | -$2,515,500 | -30% | 26 Dec 2025 |
| CHRISTOPHER W. CAIN | Director | $321,187 | 04 Jun 2025 | ||
| Matthew Ros | Director | $321,187 | 04 Jun 2025 | ||
| Peter Evan Harwin | Director | $321,187 | 04 Jun 2025 | ||
| Arlene Morris | Director | $321,187 | 04 Jun 2025 | ||
| Todd Shegog | Director | $321,187 | 04 Jun 2025 | ||
| Karen Jean Ferrante | Director | $20,011 | 01 Jan 2026 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|